Compression Works develops and manufactures hemorrhage control devices
for the EMS and Military markets. Our flagship product is the Abdominal Aortic &
Junctional Tourniquet – Stabilized (AAJT-S). We deliver innovative solutions to
meet the most pressing and unmet needs of emergency healthcare providers.
We are committed to hemorrhage control research, identifying capability gaps,
and developing technologies and products to help facilitate the delivery of
quality life-saving care. Our bleeding control solutions are used by militaries
around the world, U.S trauma centers, EMS, rural emergency departments, and
federal and local law enforcement agencies.
Uncompressible hemorrhages kill tens of thousands of people annually from
hemorrhages in the junctions of the inguinal (groin), axilla (shoulder), abdomen
and pelvis because they are difficult to access and treat.
Vehicle accidents, battlefield injuries, blunt force trauma, penetrating injuries,
gunshot wounds, blast wounds and workplac...
Compression Works develops and manufactures hemorrhage control devices
for the EMS and Military markets. Our flagship product is the Abdominal Aortic &
Junctional Tourniquet – Stabilized (AAJT-S). We deliver innovative solutions to
meet the most pressing and unmet needs of emergency healthcare providers.
We are committed to hemorrhage control research, identifying capability gaps,
and developing technologies and products to help facilitate the delivery of
quality life-saving care. Our bleeding control solutions are used by militaries
around the world, U.S trauma centers, EMS, rural emergency departments, and
federal and local law enforcement agencies.
Uncompressible hemorrhages kill tens of thousands of people annually from
hemorrhages in the junctions of the inguinal (groin), axilla (shoulder), abdomen
and pelvis because they are difficult to access and treat.
Vehicle accidents, battlefield injuries, blunt force trauma, penetrating injuries,
gunshot wounds, blast wounds and workplace accidents all contribute.
• Greater than 20% of battlefield deaths can be prevented
• 40% of pelvic fracture patients die due to bleeding that can be prevented
• Traditional treatments are ineffective and limited
Current early installed base is US Military Combat Operations. The EMS market
is a 10X opportunity in both US and International markets. The Global market
size for the AAJT-S is $2B+. Target Installations include Ambulances, Fire &
Rescue, Combat Medical Operations, Hospital Critical Care Units, Commercial
Aircraft, Nursing Homes, Schools & Universities.
Competitive Advantage: The Only device approved for: Inguinal (groin), Axilla (shoulder), Abdominal and Pelvic Fracture Bleeding Indications,
The Only device proven equivalent for Zone 3 REBOA (device to treat
impending cardiac arrest from bleeding or multiple simultaneous organ injuries),
Much easier, safer and cheaper to administer than REBOA, Easy to use – does not require precise anatomical knowledge, Uses less pressure to occlude bleeding (less tissue necrosis), Maintains secure placement during patient transport, only device supported with human safety and efficacy research, only device with published life-saving case history.
More information

Advisors

Employees

Scott Dodson
Admin
Scott Dodson CEO 30 year medical device veteran leading blue-chip, mid-cap and venture backed companies to commercial success in global markets.